NASDAQ · LUCYWHealthcareOphthalmic Goods

Innovative Eyewear, Inc. Series A Warrants 8/16/27 financials

$0.0351−0.57%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
FY24
Dec 31
FY23
Dec 31
FY22
Dec 31
Revenue$2.7M$1.6M$1.2M$659.8K
Gross profit$567.5K$215.2K-$119.3K-$56.3K
Gross margin21.3%13.1%−10.4%−8.5%
Operating income-$8.5M-$7.9M-$6.9M-$5.6M
Net income-$7.6M-$7.8M-$6.7M-$5.7M
Net margin−285.2%−474.6%−578.2%−861.2%
Diluted EPS$-1.90$-5.19$-10.87$-17.40
EBITDA-$8.4M-$7.7M-$6.8M-$5.5M
Operating cash flow-$7.3M-$6.7M-$5.8M-$3.2M
Free cash flow-$7.3M-$6.8M-$5.8M-$3.3M
Diluted shares4.0M1.5M0.6M0.3M

Balance sheet

Period endDec 31Dec 31Dec 31Dec 31
Cash & equivalents$6.5M$2.6M$4.3M$3.6M
Short-term investments$0.00$4.9M$0.00$0.00
Total debt$28.5K$0.00$0.00$61.4K
Total assets$10.1M$9.8M$6.2M$4.7M
Total liabilities$1.1M$743.2K$659.9K$665.5K
Shareholders' equity$9.1M$9.1M$5.6M$4.0M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology